Journal Of Experimental & Clinical Cancer Research Impact Factor

8 min read

Introduction

The Journal of Experimental & Clinical Cancer Research impact factor is a numeric indicator that reflects how frequently articles published in this peer‑reviewed oncology journal are cited by other scientific works. Now, understanding this metric is essential for researchers, university administrators, and funding bodies who use journal prestige as a proxy for scholarly influence. In this article we will explore what the impact factor represents, how it is calculated, why it matters, and address common misconceptions that often cloud its interpretation Most people skip this — try not to. No workaround needed..

Detailed Explanation

Background and Scope of the Journal

The Journal of Experimental & Clinical Cancer Research (JECCR) is a well‑established outlet that publishes original research spanning laboratory investigations (experimental) and human trials (clinical) in oncology. So its scope includes molecular mechanisms of tumor development, novel therapeutic strategies, biomarkers, immunology, and translational studies that bridge the laboratory to bedside. Because the journal serves a multidisciplinary audience, its citation patterns are diverse, ranging from basic science papers to large‑scale clinical trial reports.

What Is an Impact Factor?

An impact factor (IF) is a yearly average that quantifies the number of citations received by articles published in a specific journal over a defined period, usually the preceding two years. The formula is:

[ \text{Impact Factor} = \frac{\text{Total citations in year X to articles published in years X‑1 and X‑2}}{\text{Total number of citable articles published in years X‑1 and X‑2}}. ]

The numerator counts citations from any source, while the denominator counts only those articles that are indexed in the citation database (typically the Journal Citation Reports, JCR). The resulting figure is then rounded to two decimal places Easy to understand, harder to ignore. No workaround needed..

Why the Impact Factor Matters

  1. Research Visibility – Journals with higher IFs tend to attract more downloads and citations, amplifying the reach of the published work.
  2. Institutional Evaluation – Universities and funding agencies often use IF as a quick benchmark when assessing departmental performance or allocating resources.
  3. Career Advancement – Researchers may reference a journal’s IF when deciding where to submit a manuscript, believing a higher‑impact venue will enhance their professional profile.

Step‑by‑Step Concept Breakdown

1. Locate the Journal in the Journal Citation Reports

  • Visit the Web of Science or Journal Citation Reports platform.
  • Search for “Journal of Experimental & Clinical Cancer Research.”
  • Identify the most recent 2023 and 2022 impact factor values.

2. Interpret the Numbers

  • 2023 IF = 5.42 (example). Put another way,, on average, articles published in 2021 and 2022 received 5.42 citations each during 2023.
  • Compare this figure with related oncology journals (e.g., Cancer Research IF ≈ 70, Journal of Clinical Oncology IF ≈ 30) to gauge relative standing.

3. Examine Quartile Position

  • JCR assigns each journal to a quartile (Q1–Q4), with Q1 representing the top 25 % of journals in its field.
  • If JECCR is placed in Q2, it sits in the upper half of oncology journals, indicating respectable but not elite influence.

4. Track Trends Over Time

  • Plot the IF for the past five years.
  • A rising trend suggests growing impact, while a declining trend may signal stagnation or shifting research priorities.

Real Examples

Example 1: High‑Impact Clinical Trial

A 2022 randomized phase III trial on immunotherapy for metastatic melanoma, published in JECCR, amassed over 250 citations within two years. The study’s rigorous design and high‑profile results propelled the journal’s IF upward, illustrating how a single influential paper can affect the metric Nothing fancy..

Example 2: Niche Experimental Study

A 2021 article describing a novel cell‑culture model for breast cancer metabolism received 12 citations. Though the absolute citation count is modest, the paper’s methodological contribution enriched the experimental cancer research field, underscoring that IF alone does not capture niche value And that's really what it comes down to..

Scientific or Theoretical Perspective

The impact factor rests on the premise that scholarly influence can be measured through citation counts, a concept rooted in bibliometrics. While the metric provides a macro‑level view of a journal’s reach, it has several theoretical limitations:

  • Field‑Specific Citation Practices – Some disciplines cite more frequently than others; oncology may have a higher citation half‑life than, say, pure mathematics.
  • Time Lag – Articles often receive citations after a delay, meaning the two‑year window can underrepresent the true long‑term impact.
  • Self‑Citation and Journal Policies – Some journals encourage self‑citation or have policies that affect citation counts, potentially inflating IFs.

Researchers increasingly complement IF with alternative metrics such as CiteScore, Article Influence Index, or altmetrics (social media mentions, policy documents) to obtain a fuller picture of scholarly impact Worth keeping that in mind..

Common Mistakes or Misunderstandings

  • Assuming IF Equals Article Quality – A high IF reflects the aggregate citation

Assuming IF Equals Article Quality – A high IF reflects the aggregate citation output of a journal, but it does not guarantee that every article published within its pages will be seminal or even well‑received by the community Worth keeping that in mind. But it adds up..

Beyond the Impact Factor: Complementary Metrics

Researchers and institutions increasingly recognize that a single scalar value cannot capture the multidimensional nature of scholarly influence. To obtain a richer portrait, many turn to alternative citation indices such as:

Metric Calculation Typical Range (Oncology) Strengths Limitations
CiteScore (Scopus) Total citations in 3 years ÷ total citable documents in same period 2–8 Longer citation window, includes conference proceedings Still subject to field‑specific citation habits
SCImago Journal Rank (SJR) Weighted citations per article, emphasizing citations from high‑ prestige journals 0.But 8–3. Now, 5–2. 0 Adjusts for disciplinary differences Requires up‑to‑date field norms
Article Influence Score (AIS) 5‑year IF divided by the median article number in the journal 0.5 Reflects citation quality, not just quantity Complex algorithm, less transparent
SNIP (Source Normalized Impact per Paper) Cites per document normalized by field‑specific citation factor 0.5–3.

By triangulating these indicators, a journal’s standing can be placed within a more nuanced hierarchy. To give you an idea, a journal with a modest IF but a high SJR may be revered for publishing work that is frequently referenced in high‑impact studies, whereas a high IF coupled with low altmetric activity might suggest limited engagement beyond academia.

When the Impact Factor Can Be Misleading

Even a well‑calculated IF may mislead if interpreted in isolation. Common pitfalls include:

  • Citation Lag: Oncology research often requires several years before clinicians adopt new findings. A two‑year window can understate the influence of breakthrough trials.
  • Field‑Specific Citation Norms: Some sub‑specialties (e.g., hematologic malignancies) cite more aggressively than others (e.g., rare pediatric cancers). Direct comparisons across sub‑fields can be deceptive.
  • Self‑Citation Policies: Journals that encourage authors to cite their own prior work, or that publish thematic issues with high internal citation rates, can inflate the IF without a corresponding increase in external impact.
  • Article Type Distribution: A surge of highly cited review articles can boost the IF while the journal’s primary research output remains less referenced.

Understanding these nuances helps readers avoid over‑ or under‑valuing a journal’s overall contribution Most people skip this — try not to..

Practical Guidance for Different Stakeholders

For Researchers

When deciding where to submit a manuscript, consider the following checklist:

  1. Alignment of Scope – Does the journal’s focus match the study’s subject?
  2. Citation Profile – Review IF, CiteScore, and SJR together; prioritize journals where the target audience habitually cites.
  3. Peer‑Review Rigor – Look for editorial policies that ensure thorough review and reproducibility.
  4. Open‑Access Options – If visibility is a priority, assess article processing charges and licensing terms.

For Editors and Publishers

  • Strategic Investment: Allocate resources to publish high‑visibility studies (e.g., phase III trials) that can

significantly influence the journal’s citation metrics and, by extension, its IF. Even so, it is equally critical to invest in methodological rigor and transparency. Implementing clear editorial policies—such as limiting self-citations, promoting open data practices, and encouraging diverse article types—can help mitigate metric-driven distortions. Additionally, fostering collaborations with preeminent researchers in the field can attract high-quality submissions while aligning the journal with evolving scholarly communication trends.

Real talk — this step gets skipped all the time.

For Librarians and Institutions

For those managing journal subscriptions or evaluating institutional output, metrics should inform, not dictate, decisions. Consider the following:

  • Contextual Relevance: A journal’s impact may vary across disciplines or career stages. Prioritize sources that align with specific research goals or pedagogical needs.
  • Cost-Benefit Analysis: Factor in accessibility, licensing models, and the availability of supplementary materials when assessing value. Open-access journals, for example, may offer broader reach despite higher APCs.
  • Diverse Metrics Portfolio: Track altmetrics alongside traditional indicators to gauge public engagement or policy influence, particularly for interdisciplinary or translational research.

Conclusion

The landscape of academic publishing is increasingly data-rich, yet the interpretation of journal metrics remains fraught with complexity. While the Impact Factor has long reigned as a proxy for prestige, its limitations—from citation lag to field-specific idiosyncrasies—underscore the need for a multifaceted approach. By integrating complementary metrics like SJR, AIS, and altmetrics, stakeholders can construct a more holistic portrait of a journal’s influence and relevance Small thing, real impact..

For researchers, this means scrutinizing metrics alongside scope and accessibility to ensure alignment with their work’s goals. Editors and publishers, meanwhile, must balance strategic investments in high-impact content with ethical practices that safeguard scholarly integrity. Librarians and institutions, too, play a critical role in translating these metrics into actionable insights for resource allocation and knowledge dissemination That's the part that actually makes a difference..

Most guides skip this. Don't.

At the end of the day, no single metric can capture the full spectrum of a journal’s contribution to science and society. By embracing a nuanced, evidence-based framework, the academic community can move beyond reductive rankings toward a more equitable and insightful evaluation of scholarly excellence.

New Additions

The Latest

More of What You Like

Expand Your View

Thank you for reading about Journal Of Experimental & Clinical Cancer Research Impact Factor. We hope the information has been useful. Feel free to contact us if you have any questions. See you next time — don't forget to bookmark!
⌂ Back to Home